GKWIM
BNTX icon

Gerber Kawasaki Wealth & Investment Management’s BioNTech BNTX Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,260
Closed -$324K – 256
2021
Q4 		$324K Buy
1,260
+80
+7% +$21.9K 0.03% 196
2021
Q3 		$322K Buy
+1,180
New +$375K 0.04% 131

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's BNTX Position: Q1 2022 in Review

Gerber Kawasaki Wealth & Investment Management sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 1,260 shares — an estimated $324K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in BNTX in Q3 2021 and held it in 2 quarters. The position peaked at $324K in Q4 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 1,260 BioNTech shares in Q1 2022, an estimated $324K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in BioNTech in Q3 2021 and held it in 2 quarters.
  • Gerber Kawasaki Wealth & Investment Management's BioNTech position peaked at $324K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q1 2022, filed 12 May 2022.